Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Management of hypoparathyroidism].

Noriyuki Namba1, Keiichi Ozono

  • 1Department of Pediatrics, Osaka University Graduate School of Medicine.

Clinical Calcium
|December 3, 2005
PubMed
Summary

Therapy for hypoparathyroidism aims to normalize serum calcium levels using calcium and vitamin D. This review covers current treatments and discusses future therapeutic options for managing hypocalcemia and preventing complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

WT1 peptide vaccines of post-allogeneic HSCT maintenance immunotherapy for pediatric acute leukemias: a phase II study.

Blood advances·2026
Same author

Clinical and Genetic Characterization of Osteogenesis Imperfecta in Japanese Patients: Outcomes of Sequential Bisphosphonate Therapy.

Calcified tissue international·2026
Same author

Real-world Impact of Treatment on Growth in Children With X-Linked Hypophosphatemia.

The Journal of clinical endocrinology and metabolism·2026
Same author

Interplay between DYRK1A dosage and aneuploidy-induced neuropathology in Down syndrome.

Communications biology·2026
Same author

NEFL is associated with inhibition of odontoblastic process in odontohypophosphatasia.

Journal of bone and mineral metabolism·2026
Same author

Pathways to Facilitate Early Recognition and Diagnosis of Hypochondroplasia.

Advances in therapy·2026

Area of Science:

  • Endocrinology
  • Metabolic Bone Diseases

Context:

  • Hypoparathyroidism presents challenges in calcium homeostasis.
  • Therapeutic goals include symptom alleviation and complication prevention.

Purpose:

  • To review current pharmacologic agents for hypoparathyroidism.
  • To discuss management strategies for calcium and vitamin D therapy.
  • To explore emerging therapeutic options.

Summary:

  • The primary objective in treating hypoparathyroid states is to achieve adequate serum calcium levels.
  • Calcium and vitamin D preparations are the cornerstone of current pharmacologic management.
  • This review examines the established use of these agents and anticipates future advancements.

Impact:

  • Provides a comprehensive overview of hypoparathyroidism management.
  • Informs clinical practice regarding calcium and vitamin D therapy.
  • Highlights potential future directions in treating hypoparathyroid disorders.

Related Experiment Videos